Erratum: Real-world evidence of long-term survival and healthcare resource use in patients with hepatic encephalopathy receiving rifaximin-α treatment: a retrospective observational extension study with long-term follow-up (IMPRESS II)

[This corrects the article DOI: 10.1136/flgastro-2022-102221.]. © Author(s) (or their employer(s)) 2024. No commercial re-use. See rights and permissions. Published by BMJ.... ...

请注册登录后继续浏览